Jan 8, 2017
Analyst Activity – Jefferies Group Reiterates Positive on The Medicines Company (NASDAQ:MDCO)
Analyst Activity – Jefferies Group Reiterates Positive on The Medicines Company (NASDAQ:MDCO)
Analyst Ratings For The Medicines Company (NASDAQ:MDCO) Today, Jefferies Group reiterated its Positive rating on The Medicines Company (NASDAQ:MDCO) with a price target of $49.00. There are 2 hold ratings, 10 buy ratings on the stock. The current consensus rating on The Medicines Company (NASDAQ:MDCO) is Buy (Score: 2.83) with a consensus target price of $52.78 per share, a potential 45.67%…
View On WordPress